| Posters | | | |
| Aapo Kaarlo Aapeli | Ahonen | Usefulness of I-123 ADAM in clinical research: metabolism and early clinical results |  |
| Merethe Wigen | Andersen | Introducing the new EANM paediatric dosage card in our nuclear medicine department - initial | |
| | | experience and results |  |
| Kim Francis | Andersen | Prognostic factors related to long-term survival in patients with known ischemic heart disease | |
| | | depending on myocardial perfusion imaging outcome |  |
| Tone | Cappelen | Thyroid cancer patients receiving 131-iodine therapy: hospitalisation or not? | |
| Trine | Hjørnevik | Rat model of pathological pain in the central nervous system |  |
| Kjersti | Johnsrud | Characterization of an add-on directionally shielding for a gamma probe for use in sentinel |  |
| | | node localisation | |
| Jonas | Jögi | Heart failure diagnostics based on V/P SPECT and quantitative perfusion gradients |  |
| Nina | Kleven-Madsen | Risk assessment and risk management in a new Centre for Nuclear Medicine/ PET |  |
| Gunnhild | Kravdal | Optimising one-day myocardial perfusion studies on Infinia Hawkeye 4 |  |
| Thuy | Lu | Diagnostic accuracy of preoperative SPECT/CT and planar parathyroid scintigraphy | |
| | | in patients with single gland primary hyperparathyroidism |  |
| Jussi | Pärkkä | Comparison between radio-water PET and model based quantitative analysis of myocardial | |
| | | perfusion magnetic resonance |  |
| Lene | Rørdam | Peak exercise performance in Parkinsons disease before and 3 months after subthalamic | |
| | | deep brain stimulation (STN-DBS) |  |
| Rune | Sundset | Myocardial perfusion scintigraphy: an evaluation of 1121 patients examined at the University | |
| | | Hospital North Norway |  |
| Mette | Toft | Abdominal compression binder: a comparative randomised investigation |  |
| Birger | Tvedt | Simultaneous labelling of two red blood cell populations. Part of a study with the aim to | |
| | | convert blood group A to Blood group O (universal donor) |  |
| | | | |
Size postere  | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |